Back to search page

RDFR20200722001

Industrial partner sought to join a European Training Network for host-directed, epigenetic therapy in intracellular infection

RESEARCH PROFILE   REQUEST   ADD TO FAVOURITES
PRINT

 

ABSTRACT

A well-known French institute will coordinate a European Training Network that would be dedicated to repurpose mammalian (cancer) epigenetic libraries / compounds for anti-microbial therapy. To properly answer this European Commission challenge, an industrial partner is sought. Ideally, the partner will be an SME with expertise in chemistry, drug profiling, pre-clinical testing, and epigenetic analysis.


FULL DESCRIPTION

The French institute specialized in infectious diseases would like to coordinate a European Training Network with the following two main objectives:

include different intracellular pathogens previously linked to epigenetics (Leishmania, mycobacteria, maybe candida, HIV, influenza);

focus on human macrophages (to allow data comparison between teams and to create links to the clinics).

The funded beneficiaries from different sectors will provide complementary expertise:

industry SMEs (chemical synthesis, drug profiling, pre-clinical testing, epigenetic analysis, etc.);

academics (chemistry, infection biology, epigenetic regulation, etc.);

university clinics (pre-clinical testing, validation with patient material, etc.).

The industrial partner is sought. Ideally, the partner will be an SME with expertise in chemistry, drug profiling, pre-clinical testing and epigenetic analysis.

Thanks to this funding the SME can hire a PhD student and will benefit from research related cost. Also the SME may have access to additional funding opportunities at the EU level if the project is granted.

The project will take place within the framework of the European Training Network for host-directed, epigenetic therapy in intracellular infection. The call is not yet published. The deadline will be March - April 2021. The deadline for expressions of interest is September 15, 2020.


Partner expertise sought:

- Specific area of activity of the partner: A small and medium size company with expertise in chemical synthesis, drug profiling, pre-clinical testing, epigenetic analysis, etc is sought as a partner for this ITN project.

It will be a collaborative project, therefore the exact role of the selected SME will be discussed together with the other partners. The SME could be a workpackage leader.


Development Stage:

Concept stage

Programme - Call:

Evaluation scheme: Single-stage submission scheme

Acronym: European Network for host-directed, epigenetic therapy in intracellular infection

Website: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjcvL_crbvqAhWnyoUKHY9rAPoQFjACegQIBBAB&url=https%3A%2F%2Fwww.czelo.cz%2Ffiles%2FSB-AT-conference-speech.pdf&usg=AOvVaw1uyE0hokNLbl7_gd8ipU-Z

Deadline: 15/04/2021

Coordinator required: No

Sign-in or create an account

To express an interest in this profile, you must first sign in or create a new account.

If you already have an account, sign in here

Not got an account yet, sign up here

KEY INFORMATION

Country of origin
FRANCE
Profile date
22/07/2020
Deadline
15/09/2020

PARTNERSHIP(S) SOUGHT

Research cooperation agreement

CLASSIFICATIONS

INDUSTRY SECTORS
Life Sciences \ Biosciences and Health \ Recycling & Waste Management \ Drug Discovery and Drug Development \ Medical Devices
TECHNOLOGY KEYWORDS
BIOLOGICAL SCIENCES / Medicine, Human Health / Cytology, Cancerology, Oncology / BIOLOGICAL SCIENCES / Medicine, Human Health / Medical Research / BIOLOGICAL SCIENCES / Medicine, Human Health / Pharmaceutical Products / Drugs
COMMERCIAL KEYWORDS
Other human health activities
MARKET KEYWORDS
MEDICAL/HEALTH RELATED / Clinical Medicine / Oncology / MEDICAL/HEALTH RELATED / Other Medical/Health Related / Pharmaceuticals/fine chemicals

FIND OUT MORE

Contact Enterprise Europe Network Scotland by email at info@enterprise-europe-scotland.com, quoting reference number RDFR20200722001